Rheumnow Podcast

By Dr. CushMedicine Health & Fitness

Favorites
58
Followers
Typical duration
28 min
per episode

Based on Podcast App listening data

Rheumnow Podcast episodes

June 16, 2025 EULAR2025 Topic Podcast PsA 1
EULAR 2025 - Day 1 podcasts
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Using Combination csDMARDs in PsA
Deucravacitinib's Place in the PsA Treatment Algorithm?
23 min
June 16, 2025 EULAR 2025 - Day 5 podcast
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
GLP 1 Receptor Agonists in axSpA Patients
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution
29 min
June 15, 2025 EULAR 2025 - Day 4 podcast
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Emerging Therapies in Axial Spondyloarthritis
Chronic Pain in AxSpA Beyond Fibromyalgia
Novel Therapies in Axial Spondyloarthritis
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
All Rheumatoid Arthritis is Not the Same
52 min
June 14, 2025 Daily Eular 2025 Recap Day 4
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the fourth day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.

41 min
June 14, 2025 EULAR 2025 - Day 3 podcast
Deucravacitinib's Place in the PsA Treatment Algorithm?
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-axSpA
JAK Safety Update
Why is RA Difficult to Treat?
DMARD Combinations in RA Treatment
Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data
ALTO: Long-term Outcomes of APIPPRA
49 min
June 13, 2025 Daily Eular 2025 Recap Day 3
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the third day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.

37 min
June 13, 2025 EULAR 2025 - Day 2 podcast
Seronegative Arthritis Breakthroughs
Jokes Aside: The Impact of Laughter in RA
The Impact of Biologics on Methotrexate Adherence
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
Sonelokimab in PsA
Using Combination csDMARDs in PsA
25 min
June 12, 2025 Eular 2025 Day 1/2 Recap
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the first day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.
46 min
June 11, 2025 EULAR 2025 - Day 1 podcasts
Efficacy and Safety of Xeligekimab in AS
Who/When to Treat Clinically Suspect Arthralgia
8 min
June 06, 2025 MTX Fails Knee OA (6.6.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
19 min